Stress Test Results

RNS Number : 1414H
Banco Santander S.A.
30 July 2021
 

Banco Santander, S.A. ("BancoSantander"), pursuant to the securities market legislation, hereby states:

 

OTHER MATERIAL INFORMATION

 

Banco Santander reports the results it has obtained in the most recent stress test exercise carried out by the European Banking Authority (EBA) and the European Central Bank (ECB).

 

The exercise covered a three-year period (end 2020 - end 2023) with two scenarios (baseline and adverse) applied to the consolidated perimeter of Santander Group. The CET1 ratio is a financial solvency ratio introduced in 2010 with the Basel III Accord, the implementation of which is being carried out progressively by financial institutions, pursuant to the transitional implementation schedules of the Capital Requirements Directive and Regulation, and the International Financial Reporting Standard (IFRS) 9. During the phase-in period of these regulations, in addition to the CET1 Phased-in ratio (a capital ratio calculated pursuant to the transitional regime), which is the legally binding ratio, the CET1 Fully Loaded ratio (a capital ratio calculated assuming a full implementation of the aforementioned regulations) is also used for information purposes.

 

The stress test exercise results in the following projected capital ratios for Santander Group for the periods and scenarios considered. A comparison of these projected ratios with the data at the end of 2020 in terms of both the CET1 Fully Loaded ratio (11.89%) and the CET1 Phased-in ratio (12.34%) is also included in brackets:

 


ADVERSE SCENARIO

BASELINE SCENARIO


CET1 Fully Loaded

CET1 Phased- in

CET1 Fully Loaded

CET1 Phased- in

31/12/2021

8.65% (-3.24%)

10.25% (-2.08%)

12.99% (+1.10%)

13.18% (+0.85%)

31/12/2022

9.24% (-2.65%)

10.40% (-1.94%)

14.06% (+2.17%)

14.13% (+1.79%)

31/12/2023

9.31% (-2.58%)

9.93% (-2.40%)

14.94% (+3.05%)

14.94% (+2.60%)

 

 

Boadilla del Monte, Madrid, 30th July, 2021

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCEAKXEDENFEFA
UK 100

Latest directors dealings